{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:06:15Z","timestamp":1789815975425,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Increased expression of the transcription factor Forkhead box M1 (FOXM1) has been reported to play an important role in the progression and development of multiple tumors, but the molecular mechanisms that regulate FOXM1 expression remain unknown, and the role of FOXM1 in aerobic glycolysis is still not clear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of FOXM1 and NADPH oxidase 4 (NOX4) in normal brain tissues and glioma was detected in data from the TCGA database and in our specimens. The effect of NOX4 on the expression of FOXM1 was determined by Western blot, qPCR, reactive oxygen species (ROS) production assays, and luciferase assays. The functions of NOX4 and FOXM1 in aerobic glycolysis in glioblastoma cells were determined by a series of experiments, such as Western blot, extracellular acidification rate (ECAR), lactate production, and intracellular ATP level assays. A xenograft mouse model was established to test our findings in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression of FOXM1 and NOX4 was increased in glioma specimens compared with normal brain tissues and correlated with poor clinical outcomes. Aberrant mitochondrial reactive oxygen species (ROS) generation of NOX4 induced FOXM1 expression. Mechanistic studies demonstrated that NOX4-derived MitoROS exert their regulatory role on FOXM1 by mediating hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) stabilization. Further research showed that NOX4-derived MitoROS-induced HIF-1\u03b1 directly activates the transcription of FOXM1 and results in increased FOXM1 expression. Overexpression of NOX4 or FOXM1 promoted aerobic glycolysis, whereas knockdown of NOX4 or FOXM1 significantly suppressed aerobic glycolysis, in glioblastoma cells. NOX4-induced aerobic glycolysis was dependent on elevated FOXM1 expression, as FOXM1 knockdown abolished NOX4-induced aerobic glycolysis in glioblastoma cells both in vitro and in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Increased expression of FOXM1 induced by NOX4-derived MitoROS plays a pivotal role in aerobic glycolysis, and our findings suggest that inhibition of NOX4-FOXM1 signaling may present a potential therapeutic target for glioblastoma treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08933-y","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T15:02:51Z","timestamp":1636124571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiangsheng","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfa","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"issue":"4","key":"8933_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613.","journal-title":"CA Cancer J Clin"},{"key":"8933_CR2","doi-asserted-by":"publisher","first-page":"5104876","DOI":"10.1155\/2020\/5104876","volume":"2020","author":"C Festuccia","year":"2020","unstructured":"Festuccia C, Biordi AL, Tombolini V, Hara A, Bailey D. Targeted molecular therapy in glioblastoma. J Oncol. 2020;2020:5104876\u20133. https:\/\/doi.org\/10.1155\/2020\/5104876.","journal-title":"J Oncol"},{"issue":"5","key":"8933_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell."},{"issue":"8","key":"8933_CR4","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, et al. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther. 2012;11(8):1672\u201382. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0131.","journal-title":"Mol Cancer Ther"},{"key":"8933_CR5","unstructured":"Pathria G, Scott DA, Feng Y, Sang Lee J, Fujita Y, Zhang G, et al. Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. 2018;37(20). https:\/\/pubmed.ncbi.nlm.nih.gov\/31431459\/."},{"issue":"2","key":"8933_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.20101470","volume":"208","author":"A Wolf","year":"2011","unstructured":"Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011;208(2):313\u201326. https:\/\/doi.org\/10.1084\/jem.20101470.","journal-title":"J Exp Med"},{"issue":"1","key":"8933_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12(1):152. https:\/\/doi.org\/10.1186\/1476-4598-12-152.","journal-title":"Mol Cancer"},{"key":"8933_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364. https:\/\/doi.org\/10.1016\/j.semcdb.2017.05.023.","journal-title":"Semin Cell Dev Biol"},{"key":"8933_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.10.500","volume":"101","author":"C Zeng","year":"2016","unstructured":"Zeng C, Wu Q, Wang J, Yao B, Ma L, Yang Z, et al. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells. Free Radic Biol Med. 2016;101:236\u201348. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.10.500.","journal-title":"Free Radic Biol Med"},{"key":"8933_CR10","doi-asserted-by":"publisher","unstructured":"Wu D, Huang RT, Hamanaka RB, Krause M, Oh MJ, Kuo CH, et al. HIF-1alpha is required for disturbed flow-induced metabolic reprogramming in human and porcine vascular endothelium. eLife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.25217.","DOI":"10.7554\/eLife.25217"},{"issue":"Pt 1","key":"8933_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.08.009","volume":"52","author":"D Nandi","year":"2018","unstructured":"Nandi D, Cheema PS, Jaiswal N, Nag A. FoxM1: repurposing an oncogene as a biomarker. Semin Cancer Biol. 2018;52(Pt 1):74\u201384. https:\/\/doi.org\/10.1016\/j.semcancer.2017.08.009.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8933_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12885-018-4294-9","volume":"18","author":"X Jiao","year":"2018","unstructured":"Jiao X, Yu W, Qian J, Chen Y, Wei P, Fang W, et al. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1. BMC Cancer. 2018;18(1):570. https:\/\/doi.org\/10.1186\/s12885-018-4294-9.","journal-title":"BMC Cancer"},{"issue":"1","key":"8933_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-019-1202-3","volume":"38","author":"G Hu","year":"2019","unstructured":"Hu G, Yan Z, Zhang C, Cheng M, Yan Y, Wang Y, et al. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression. J Exp Clin Cancer Res. 2019;38(1):188. https:\/\/doi.org\/10.1186\/s13046-019-1202-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"8933_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7150\/ijbs.10634","volume":"11","author":"P Wei","year":"2015","unstructured":"Wei P, Zhang N, Wang Y, Li D, Wang L, Sun X, et al. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J Biol Sci. 2015;11(2):186\u201398. https:\/\/doi.org\/10.7150\/ijbs.10634.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"8933_CR15","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/carcin\/bgs249","volume":"33","author":"L Xia","year":"2012","unstructured":"Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H, et al. The TNF-alpha\/ROS\/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis. 2012;33(11):2250\u20139. https:\/\/doi.org\/10.1093\/carcin\/bgs249.","journal-title":"Carcinogenesis."},{"issue":"10","key":"8933_CR16","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1158\/1078-0432.CCR-13-2407","volume":"20","author":"J Cui","year":"2014","unstructured":"Cui J, Shi M, Xie D, Wei D, Jia Z, Zheng S, et al. FOXM1 promotes the Warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res. 2014;20(10):2595\u2013606. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2407.","journal-title":"Clin Cancer Res"},{"key":"8933_CR17","first-page":"1","volume":"2021","author":"X Su","year":"2021","unstructured":"Su X, Yang Y, Guo C, Zhang R, Sun S, Wang Y, et al. NOX4-derived ROS mediates TGF-\u03b21-induced metabolic reprogramming during epithelial-mesenchymal transition through the PI3K\/AKT\/HIF-1\u03b1 pathway in glioblastoma. Oxidative Med Cell Longev. 2021;2021:1\u201330.","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"8933_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","volume":"32","author":"AC Codo","year":"2020","unstructured":"Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1alpha\/glycolysis-dependent Axis. Cell Metab. 2020;32(3):437\u201346 e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.007.","journal-title":"Cell Metab"},{"issue":"12","key":"8933_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of Cancer progression. Trends Cancer. 2016;2(12):758\u201370. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.016.","journal-title":"Trends Cancer"},{"issue":"8","key":"8933_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/ars.2014.5973","volume":"23","author":"P Gupta","year":"2015","unstructured":"Gupta P, Jagavelu K, Mishra DP. Inhibition of NADPH Oxidase-4 potentiates 2-deoxy-D-glucose-induced suppression of glycolysis, migration, and invasion in glioblastoma cells: role of the Akt\/HIF1\u03b1\/HK-2 signaling Axis. Antioxid Redox Signal. 2015;23(8):665\u201381. https:\/\/doi.org\/10.1089\/ars.2014.5973.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"8933_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27(1):441\u201364. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"8933_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2018.04.002","volume":"28","author":"I Elia","year":"2018","unstructured":"Elia I, Doglioni G, Fendt SM. Metabolic hallmarks of metastasis formation. Trends Cell Biol. 2018;28(8):673\u201384. https:\/\/doi.org\/10.1016\/j.tcb.2018.04.002.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"8933_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nov125","volume":"18","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Zadeh G. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions. Neuro-Oncology. 2016;18(2):160\u201372. https:\/\/doi.org\/10.1093\/neuonc\/nov125.","journal-title":"Neuro-Oncology"},{"issue":"6","key":"8933_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10565-017-9381-1","volume":"33","author":"WX Peng","year":"2017","unstructured":"Peng WX, Han X, Zhang CL, Ge L, Du FY, Jin J, et al. FoxM1-mediated RFC5 expression promotes temozolomide resistance. Cell Biol Toxicol. 2017;33(6):527\u201337. https:\/\/doi.org\/10.1007\/s10565-017-9381-1.","journal-title":"Cell Biol Toxicol"},{"issue":"19","key":"8933_CR25","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/emboj.2009.239","volume":"28","author":"HJ Park","year":"2009","unstructured":"Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 2009;28(19):2908\u201318. https:\/\/doi.org\/10.1038\/emboj.2009.239.","journal-title":"EMBO J"},{"key":"8933_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","volume":"104","author":"S Galadari","year":"2017","unstructured":"Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144\u201364. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.004.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"8933_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ijc.23569","volume":"123","author":"T Shono","year":"2008","unstructured":"Shono T, Yokoyama N, Uesaka T, Kuroda J, Takeya R, Yamasaki T, et al. Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival. Int J Cancer. 2008;123(4):787\u201392. https:\/\/doi.org\/10.1002\/ijc.23569.","journal-title":"Int J Cancer"},{"issue":"1","key":"8933_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11060-015-1889-8","volume":"125","author":"MO Yu","year":"2015","unstructured":"Yu MO, Park KJ, Park DH, Chung YG, Chi SG, Kang SH. Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma. J Neuro-Oncol. 2015;125(1):55\u201363. https:\/\/doi.org\/10.1007\/s11060-015-1889-8.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"8933_CR29","doi-asserted-by":"publisher","first-page":"e1056442","DOI":"10.1080\/2162402X.2015.1056442","volume":"5","author":"MM Leblond","year":"2016","unstructured":"Leblond MM, Gerault AN, Corroyer-Dulmont A, MacKenzie ET, Petit E, Bernaudin M, et al. Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models. Oncoimmunology. 2016;5(1):e1056442. https:\/\/doi.org\/10.1080\/2162402X.2015.1056442.","journal-title":"Oncoimmunology."},{"issue":"6","key":"8933_CR30","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/1878-0261.12666","volume":"14","author":"R Shang","year":"2020","unstructured":"Shang R, Wang M, Dai B, Du J, Wang J, Liu Z, et al. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3\/FOXM1\/GLUT1 pathway. Mol Oncol. 2020;14(6):1381\u201396. https:\/\/doi.org\/10.1002\/1878-0261.12666.","journal-title":"Mol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08933-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T15:02:56Z","timestamp":1636124576000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08933-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8933"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08933-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethical Review Committee of Shandong Provincial Hospital (Jinan, China). All animal procedures were approved by the Animal Care Committee of Shandong Provincial Hospital (Jinan, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1181"}}